Doctors without borders and the moral economy of pharmaceuticals

Human Rights in Crisis

Volumn , Issue , 2017, Pages 129-144

  Redfield, Peter ^a  

^a UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85084542299     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4324/9781315587523-9     Document Type: Chapter

References (45)

1. Biehl, João (2006), “Pharmaceutical Governance,” in Adriana Petryna, Andrew Lakoff, and Arthur Kleinman, eds, Global Pharmaceuticals: Ethics, Markets, Practices, Durham, NC: Duke University Press, 206-239.
2. Barnett, Michael (2005), “Humanitarianism Transformed,” Perspectives on Politics. 3: 4: 723-740.
3. Bortolotti, Dan (2004), Hope in Hell: Inside the World of Doctors Without Borders, Buffalo: Firefly Books.
4. Bradol, Jean-Hervé (2004), “Introduction: The Sacrificial International Order and Humanitarian Action.” in Frabrice Weissman, ed., In the Shadow of Just Wars: Violence, Politics and Humanitarian Action, Ithaca, NY: Médecins Sans Frontières and Cornell University Press, pp. 1-22.
5. Brauman, Rony (2000), L’Action humanitaire, Paris: Flammarion.
6. Calmy, Alexandra (2005), “Alive at Five: Lessons Learned from AIDS Treatment in Resource-poor Settings,” Access News 12 (November): 1.
7. Das, Veena (1999), “Public Good, Ethics and Everyday Life: Beyond the Boundaries of Bioethics,” Daedalus, 128: 4: 99-133.
8. Daston, Lorraine (1995), “The Moral Economy of Science,” Osiris, 2nd Series, 10, Constructing Knowledge in the History of Science, 2-24.
9. DNDi (2004), “An Innovative Solution,” Informational brochure, April 2004.
10. Dumit, Joseph (2002), “Drugs for Life,” Molecular Interventions 2: 3: 124-127.
11. Farmer, Paul (2003), Pathologies of Power: Health, Human Rights, and the New War on the Poor, Berkeley: University of California Press.
12. Fox, Renée (1995), “Medical Humanitarianism and Human Rights: Reflections on Doctors without Borders and Doctors of the World,” Social Science and Medicine, 41(12): 1607-1616.
13. Heald, Suzette (2003), “An Absence of Anthropology: Critical Reflections on Anthropology and AIDS policy and practice in Africa,” in George Ellison, Melissa Parker and Catherine Campbell, eds, Learning from HIV and AIDS, Cambridge: Cambridge University Press, 210-237.
14. Hoen, Ellen ’t. (2002), “TRIPS, Pharmaceutical Patents, and Access to Essential Medicines: A Long Way from Seattle to Doha,” Chicago Journal of International Law. 3: 1: 27-46.
15. Kleinman, Arthur, Veena Das, and Margaret Lock, eds (1997), Social Suffering, Berkeley: University of California Press.
16. Lakoff, Andrew (2006), Pharmaceutical Reason: Knowledge and Value in Global Psychiatry, Cambridge: Cambridge University Press.
17. Laplante, Julie (2003), “Le Médicament aux frontières des saviors humanitaires et autochtones,” Anthropologie et Sociétés, 27: 2: 59-75.
18. Leopold, Mark (2005), Inside West Nile: Violence, History and Representation on an African Frontier, Santa Fe, NM: School of American Research Press.
19. Lyons, Maryinez (1992), The Colonial Disease: A Social History of Sleeping Sickness in Northern Zaire, 1900-1940, Cambridge: Cambridge University Press.
20. Médecins Sans Frontières (MSF) (2000), Activity Report, 1999-2000, MSF International.
21. Médecins Sans Frontières (MSF) (2001a), “Fatal Imbalance: The Crisis in Research and Development for Drugs for Neglected Diseases,” MSF Campaign for Access to Essential Medicines/Drugs for Neglected Diseases Working Group Report.
22. Médecins Sans Frontières (MSF) (2001b), “Supply of Sleeping Sickness Drugs Secured,” Press Release, New York/Geneva, May 3, 2001.
23. Médecins Sans Frontières (MSF) (2002), “AIDS: The Urgency to Treat,” Supplement to Messages, 123. December.
24. Médecins Sans Frontières (MSF) (2003), “Access: Three Years On,” Access News, 8 (February).
25. Médecins Sans Frontières (MSF) (2004), “Access to Medicines at Risk Across the Globe: What to Watch out for in Free Trade Agreements with the United States,” MSF Campaign for Access to Essential medicines Briefing Note (May).
26. Médecins Sans Frontières (MSF) (2005), Activity Report, 2004-5, MSF International.
27. Médecins Sans Frontières (MSF) (2006), “Too Little for Too Few: Challenges for Effective and Accessible Antiretroviral Treatment,” Briefing document, XVI International AIDS Conference, Toronto, 2006.
28. Merry, Sally Engle (2006), Human Rights & Gender Violence, Chicago: University of Chicago Press.
29. Nguyen, Vinh-Kim (2005), “Anti-retroviral Globalism, Biopolitics and Therapeutic Citizenship,” in Aihwa Ong and Stephen Collier, eds, Global Assemblages, Malden, MA: Blackwell, 124-144.
30. Petryna, Adriana (2005), “Ethical variability: Drug development and globalizing clinical trials,” American Ethnologist, 32: 2: 183-197.
31. Petryna, Adriana, Andrew Lakoff, and Arthur Kleinman, eds (2006), Global Pharmaceuticals: Ethics, Markets, Practices, Durham, NC: Duke University Press.
32. Rabinow, Paul (1999), French DNA: Trouble in Purgatory, Chicago: University of Chicago Press.
33. Rankin, Johanna (2005), A New Frontier for Humanitarianism? Médecins Sans Frontiers Responds to Neglected Diseases, unpublished Honors Thesis, International Studies, UNC-Chapel Hill.
34. Redfield, Peter (2006), “A Less Modest Witness: Collective Advocacy and Motivated Truth of a Medical Humanitarian Movement,” American Ethnologist, 33: 1: 3-26.
35. Rieff, David (2002), A Bed for the Night: Humanitarianism in Crisis, NY: Simon & Schuster.
36. Riles, Annelise (2006), “Anthropology, Human Rights, and Legal Knowledge: Culture in the Iron Cage,” American Anthropologist, 108: 1: 52-65.
37. Semakula John Kiwanuka (2002), “No Longer Asleep: African Sleeping Sickness is Back,” Medilinks 31 May, 2002, http://medilinks.org.
38. Thompson, E.P. (2001), “The Moral Economy of the English Crowd in the Eighteenth Century,” in Dorothy Thompson, ed., The Essential E.P. Thompson, New York: New Press, 316-377.
39. Vallaeys, Anne (2004), Médecins Sans Frontières: La biographie, Paris: Fayard.
40. Van der Geest, Sjaak, Susan Reynolds Whyte, and Anita Hardon (1996), “The Anthropology of Pharmaceuticals: A Biographical Approach,” Annual Review of Anthropology, 25: 153-178.
41. Vaughn, Megan (1991), Curing Their Ills: Colonial Power and African Illness, Stanford: Stanford University Press.
42. Weissman, Fabrice (2004), In the Shadow of “Just Wars”: Violence, Politics and Humanitarian Action, Ithaca, NY: Médecins Sans Frontières/Cornell University Press.
43. Whyte, Susan R., Sjaak Van der Geest, and Anita Hardon (2002), Social Lives of Medicines, Cambridge: Cambridge University Press.
44. Whyte, Susan R., Michael Whyte, Lotte Meinert, and Betty Kyaddondo (2006), in Adriana Petryna, Andrew Lakoff, and Arthur Kleinman, eds, Global Pharmaceuticals: Ethics, Markets, Practices, Durham, NC: Duke University Press, 240-262.
45. Wilson, Richard, ed. (1997), Human Rights: Culture and Context (London: Pluto Press).